[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,213,288
  • Shares Outstanding, K 61,903
  • Annual Sales, $ 0 K
  • Annual Income, $ -255,840 K
  • EBIT $ -305 M
  • EBITDA $ -311 M
  • 60-Month Beta 0.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.54

Options Overview Details

View History
  • Implied Volatility 7.76% (-0.72%)
  • Historical Volatility 121.77%
  • IV Percentile 1%
  • IV Rank 0.73%
  • IV High 200.16% on 07/03/25
  • IV Low 6.34% on 06/23/26
  • Expected Move (DTE 21) 1.79 (1.35%)
  • Put/Call Vol Ratio 1.74
  • Today's Volume 472
  • Volume Avg (30-Day) 1,239
  • Put/Call OI Ratio 3.01
  • Today's Open Interest 19,784
  • Open Int (30-Day) 10,160
  • Expected Range 130.91 to 134.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.10
  • Number of Estimates 3
  • High Estimate $-1.05
  • Low Estimate $-1.13
  • Prior Year $-1.13
  • Growth Rate Est. (year over year) +2.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.86 +74.93%
on 05/27/26
133.16 -0.35%
on 06/23/26
+49.89 (+60.25%)
since 05/26/26
3-Month
75.00 +76.93%
on 05/21/26
133.16 -0.35%
on 06/23/26
+54.28 (+69.22%)
since 03/26/26
52-Week
34.34 +286.43%
on 08/08/25
133.16 -0.35%
on 06/23/26
+88.89 (+202.90%)
since 06/26/25

Most Recent Stories

More News
Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

REFI : 11.26 (+2.09%)
TECH : 70.95 (+0.35%)
APGE : 132.67 (-0.01%)
BOLD : 2.52 (+0.40%)
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Apogee Therapeutics...

APGE : 132.67 (-0.01%)
ABBV : 247.69 (+1.87%)
AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.

Apogee’s rally may be over, but AbbVie’s upside from the deal could just be getting started.

APGE : 132.67 (-0.01%)
$SPX : 7,368.02 (+0.14%)
ABBV : 247.69 (+1.87%)
The $11 Billion Reason Abbvie Stock Is Up Today

AbbVie stock rallied today on the $10.9 billion acquisition of Apogee Therapeutics. Here’s how you should play ABBV shares at current levels.

APGE : 132.67 (-0.01%)
JNJ : 252.99 (+3.31%)
LLY : 1,199.46 (+6.36%)
ABBV : 247.69 (+1.87%)
REGN : 636.33 (+2.61%)
SNY : 42.73 (+2.22%)
US stocks drift after oil prices ease and Big Tech stocks fall

U.S. stocks drifted through a mixed day of trading after oil prices eased and falling Big Tech stocks weighed on Wall Street

APGE : 132.67 (-0.01%)
AVGO : 371.75 (-1.89%)
$SPX : 7,368.02 (+0.14%)
$DOWI : 52,092.94 (+0.33%)
CME : 222.56 (-1.08%)
ABBV : 247.69 (+1.87%)
$IUXX : 29,264.98 (-0.60%)
AMZN : 232.42 (+2.38%)
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.19%. September...

GOOGL : 343.25 (-0.13%)
AAPL : 278.47 (+1.21%)
SNDK : 2,175.00 (-6.85%)
ADI : 388.96 (-6.93%)
TSLA : 386.29 (+2.98%)
STX : 951.29 (-7.22%)
AMD : 517.07 (-2.91%)
DFTX : 44.96 (+0.38%)
SPY : 735.77 (+0.20%)
META : 555.91 (+2.40%)
NOC : 504.81 (+1.10%)
FRVO : 33.13 (+4.31%)
Are ACA, CZR, APGE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

APGE : 132.67 (-0.01%)
CZR : 30.25 (-0.53%)
ACA : 144.88 (-0.06%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apogee Therapeutics, Inc. (NASDAQ: APGE)

NEW YORK , June 22, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

APGE : 132.67 (-0.01%)
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders

MILWAUKEE , June 22, 2026 /PRNewswire/ -- Ademi LLP is investigating Apogee (NASDAQ: APGE) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

APGE : 132.67 (-0.01%)
Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. September E-mini S&P futures...

MSTR : 87.00 (+1.96%)
GOOGL : 343.25 (-0.13%)
SNDK : 2,175.00 (-6.85%)
COIN : 148.48 (+4.18%)
STX : 951.29 (-7.22%)
AMD : 517.07 (-2.91%)
DFTX : 44.96 (+0.38%)
^BTCUSD : 60,373.81 (+1.68%)
SPY : 735.77 (+0.20%)
NOC : 504.81 (+1.10%)
FRVO : 33.13 (+4.31%)
ADSK : 195.16 (+2.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 133.13
2nd Resistance Point 133.01
1st Resistance Point 132.85
Last Price 132.67
1st Support Level 132.56
2nd Support Level 132.44
3rd Support Level 132.27

See More

52-Week High 133.16
Last Price 132.67
Fibonacci 61.8% 95.41
Fibonacci 50% 83.75
Fibonacci 38.2% 72.09
52-Week Low 34.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.